Recursion Pharmaceuticals shared its third-quarter results and named Fred Hassan as the new Board Chair.

Nov 2, 2026, 6:17 PM ETResultsRead the original at SEC EDGAR

Neutral

RXRX named Fred Hassan board chair and referenced quarterly results and conference data, but this filing gives no figures or findings. It does not show a clear change in the company's outlook.

RXRX · Recursion Pharmaceuticals, Inc.

AI read · Neutral

The AI's read

The filing points to separate reports and conference data, but does not include their figures or findings. The board appointment also comes without details showing a business change. These facts do not support a clear change in RXRX's outlook.

Get alerts for RXRX

Follow Recursion Pharmaceuticals, Inc. (RXRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RXRX

Free on the App Store and Google Play, or on the web.